Ascendis Pharma A/S announced that on January 14, 2025, it granted 82,103 warrants to employees, allowing them to purchase shares at $131.57 each. The warrants will vest over time, with 25% after one year and the rest monthly thereafter, and there are 1,978,013 additional warrants available for future grants.